<address id="3xt9h"></address>

        <form id="3xt9h"></form>

          [Skip to Content]
          Sign In
          Individual Sign In
          Create an Account
          Institutional Sign In
          OpenAthens Shibboleth
          [Skip to Content Landing]

          Year

          Day

          November 18, 2020
          Original Investigation

          Association of Borderline Personality Disorder Criteria With Suicide Attempts: Findings From the Collaborative Longitudinal Study of Personality Disorders Over 10 Years of Follow-up

          Abstract Full Text
          JAMA Psychiatry. Published online November 18, 2020. doi:10.1001/jamapsychiatry.2020.3598

          This study examines prospective factors associated with suicide attempts among participants over 10 years of follow-up, with a focus on borderline personality disorder and its diagnostic criteria.

          Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017

          Abstract Full Text
          JAMA Psychiatry. Published online November 18, 2020. doi:10.1001/jamapsychiatry.2020.3550

          This cross-sectional study evaluates prevalence and trends in suicidality (suicidal ideation and/or intentional self-harm) among commercially insured childbearing individuals 1 year before and following birth.

          Special Communication

          Leveraging Basic Science for the Clinic—From Bench to Bedside

          Abstract Full Text
          JAMA Psychiatry. Published online November 18, 2020. doi:10.1001/jamapsychiatry.2020.3656

          This Special Communication offers the authors’ thoughts on new approaches to psychiatric research using animal models and other techniques.

          November 11, 2020
          Original Investigation

          Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis

          Abstract Full Text
          open access
          JAMA Psychiatry. Published online November 11, 2020. doi:10.1001/jamapsychiatry.2020.3554

          This mendelian randomization analysis investigates the potential bidirectional associations between the genetic liability for prescription opioid and other nonopioid pain medications and both major depressive disorder and anxiety and stress-related disorders using genetically based methods

          JAMA Network Insights

          Five Things to Know When a Psychiatric Patient Is Prescribed Opioids for Pain

          Abstract Full Text
          JAMA Psychiatry. Published online November 11, 2020. doi:10.1001/jamapsychiatry.2020.3547

          This essay describes how psychiatrists can play an important role in optimizing care for patients who have been prescribed opioids for chronic pain.

          November 4, 2020
          Viewpoint

          Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia

          Abstract Full Text
          JAMA Psychiatry. Published online November 4, 2020. doi:10.1001/jamapsychiatry.2020.3564

          This Viewpoint reviews reports that relied on 4 genetic methods capable of addressing the nature of the cannabis-schizophrenia association.

          Editorial

          Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression—Quo Vadis?

          Abstract Full Text
          JAMA Psychiatry. Published online November 4, 2020. doi:10.1001/jamapsychiatry.2020.2901
          Original Investigation

          Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment: A Randomized Clinical Trial

          Abstract Full Text
          JAMA Psychiatry. Published online November 4, 2020. doi:10.1001/jamapsychiatry.2020.3446

          This randomized clinical trial assesses whether cognitive bias modification would increase the likelihood of abstaining from alcohol during the 2 weeks following discharge from inpatient withdrawal treatment in adult patients with alcohol use disorder.

          Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

          Abstract Full Text
          open access has audio
          JAMA Psychiatry. Published online November 4, 2020. doi:10.1001/jamapsychiatry.2020.3285

          This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.

          Research Letter

          Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-Label Clinical Trial

          Abstract Full Text
          open access
          JAMA Psychiatry. Published online November 4, 2020. doi:10.1001/jamapsychiatry.2020.3567

          This cohort study examines whether consumption of a high-cannabidiol product resulted in detectable amounts of Δ9-tetrahydrocannabinol metabolites in the urine samples of participants.

          ×
          4887王中王鉄算 盘开奖结果小说